146 related articles for article (PubMed ID: 9139339)
1. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
2. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
Erne P
Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
[TBL] [Abstract][Full Text] [Related]
3. [Cardio-protection and cardio-reparation in systemic arterial hypertension].
Vallés Belsué F; Anguita Sánchez M
Rev Esp Cardiol; 1997; 50 Suppl 4():49-52. PubMed ID: 9411587
[TBL] [Abstract][Full Text] [Related]
4. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
Rubattu S; Volpe M; Raman V; Lindpaintner K
Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
[No Abstract] [Full Text] [Related]
5. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
Perdigão C
Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
[TBL] [Abstract][Full Text] [Related]
6. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
7. Salt and left ventricular hypertrophy: what are the links?
Langenfeld MR; Schmieder RE
J Hum Hypertens; 1995 Nov; 9(11):909-16. PubMed ID: 8583471
[TBL] [Abstract][Full Text] [Related]
8. [Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system].
Benetos A
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():21-4. PubMed ID: 7646306
[TBL] [Abstract][Full Text] [Related]
9. Cardiac consequences of aldosterone excess in human hypertension.
Rossi GP
Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
[No Abstract] [Full Text] [Related]
10. [Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system].
Lerch R; Montessuit C
Praxis (Bern 1994); 1997 Feb; 86(7):238-41. PubMed ID: 9139340
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
Phillips RA; Diamond JA; Gharavi A
Mt Sinai J Med; 1998 Mar; 65(2):97-103. PubMed ID: 9520512
[No Abstract] [Full Text] [Related]
12. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
13. [Arterial hypertension, correlated factors and cardiovascular risk].
Pessina AC; Casiglia E; Rossi GP; Semplicini A
Cardiologia; 1991 Dec; 36(12 Suppl 1):67-78. PubMed ID: 1841807
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implications.
Thürmann PA
Int J Clin Pharmacol Ther; 1997 May; 35(5):181-7. PubMed ID: 9174872
[TBL] [Abstract][Full Text] [Related]
15. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
17. [Hypertrophy and ventricular remodeling in systemic arterial hypertension: role of AT1 receptors].
Troyo Barriga P
Arch Cardiol Mex; 2003; 73 Suppl 1():S146-9. PubMed ID: 12966667
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy and remodelling of resistance arteries: the role of activation of the renin-angiotensin-aldosterone system in hypertension.
Hayoz D
J Hypertens; 2002 Jul; 20(7):1295-6. PubMed ID: 12131524
[No Abstract] [Full Text] [Related]
19. [Aldosterone and cardiovascular diseases, more than water and salt retention].
Duprez D
Verh K Acad Geneeskd Belg; 2002; 64(3):225-32. PubMed ID: 12238244
[TBL] [Abstract][Full Text] [Related]
20. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
Galderisi M; de Divitiis O
J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
